Providing human liver tissue and cells for biomedical research
Human Liver Tissue & Hepatocytes Research Resource (HLTHRR)
This study is all about providing researchers with healthy human liver cells to help them learn more about liver diseases, like alcoholic hepatitis, and find better treatments, which can ultimately benefit patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11061812 on NIH RePORTER |
What this research studies
This research program aims to supply normal human liver tissue and hepatocytes, along with various non-parenchymal cells, to biomedical researchers across the United States. By isolating and distributing these vital cellular resources, the program supports studies focused on liver functions, disease mechanisms, drug discovery, and toxicology. Patients can benefit indirectly as this research enhances understanding and treatment of liver diseases, including alcoholic hepatitis. The program has a long-standing history of facilitating liver research, ensuring that scientists have access to high-quality human liver cells for their investigations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with liver diseases, particularly those related to alcohol, as well as researchers studying liver function.
Not a fit: Patients with non-liver-related conditions or those not involved in research studies may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and understanding of liver diseases for patients.
How similar studies have performed: Previous research programs focused on liver tissue distribution have shown success in advancing liver disease studies and treatments.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Geller, David a — University of Pittsburgh at Pittsburgh
- Study coordinator: Geller, David a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.